Loading
NASDAQHealthcareMedical - Specialties
Latest quote
$120.87
−$0.04 · -0.03%
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest quote
$120.87
−$0.04 · -0.03%
After-hours
$120
−$0.87 · -0.72%
Sep 11, 6:27 PM ET
Regular session · ET · Market data may be delayed.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Day range
Current $120.87
52-week range
Current $120.87
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
58
Fair Value
Sentiment
58
Mixed
Risk
48
Elevated Risk
Momentum
48
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Day range
Current $120.87
52-week range
Current $120.87
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 249.13M USD | 240.98M USD | 216.19M USD | 219.08M USD | 184.34M USD |
| Cost of goods sold | 90.86M USD | 90.11M USD | 82.94M USD | 85.39M USD | 75.25M USD |
| Gross profit | 158.27M USD | 150.87M USD | 133.25M USD | 133.69M USD | 109.09M USD |
| Research and development | 20.31M USD | 19.52M USD | 19.3M USD | 20.49M USD | 15.77M USD |
| Selling, general, and administrative | 119.45M USD | 115.02M USD | 111.49M USD | 109.88M USD | 88.62M USD |
| Operating expenses | 139.76M USD | 134.53M USD | 405.33M USD | 130.37M USD | 104.39M USD |
| Interest expense | 10.69M USD | 11.86M USD | 5.7M USD | 4.77M USD | 3.89M USD |
| Depreciation and amortization | 23.27M USD | 24.53M USD | 31.57M USD | 33.13M USD | 25.07M USD |
| Operating income | 18.51M USD | 16.34M USD | −272.08M USD | 3.32M USD | 4.7M USD |
| Net income | 6.71M USD | −1.97M USD | −254.25M USD | 930K USD | 1.87M USD |
Company facts updated Sep 11, 2026.
Third-party consensus; not a GoAI recommendation.
Average target
$110
8.99% downsideCash distributions grouped by calendar year; partial years are marked.
$0.64
2025 complete year0.0% since 2021
2026 partial: $0.48
$0.64
2,021
$0.64
2,022
$0.64
2,023
$0.64
2,024
$0.64
2,025
$0.48
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 31, 2026 | $0.16Quarterly | Aug 31, 2026 | Sep 15, 2026 |
Dividend | May 29, 2026 | $0.16Quarterly | May 29, 2026 | Jun 15, 2026 |
Dividend | Feb 27, 2026 | $0.16Quarterly | Feb 28, 2026 | Mar 16, 2026 |
Dividend | Nov 28, 2025 | $0.16Quarterly | Nov 28, 2025 | Dec 15, 2025 |
Dividend | Aug 29, 2025 | $0.16Quarterly | Aug 29, 2025 | Sep 15, 2025 |
Dividend | May 30, 2025 | $0.16Quarterly | May 30, 2025 | Jun 16, 2025 |
Ex-dividend Aug 31, 2026
$0.16
Quarterly
Record Aug 31, 2026 · Payment Sep 15, 2026
Ex-dividend May 29, 2026
$0.16
Quarterly
Record May 29, 2026 · Payment Jun 15, 2026
Ex-dividend Feb 27, 2026
$0.16
Quarterly
Record Feb 28, 2026 · Payment Mar 16, 2026
Ex-dividend Nov 28, 2025
$0.16
Quarterly
Record Nov 28, 2025 · Payment Dec 15, 2025
Ex-dividend Aug 29, 2025
$0.16
Quarterly
Record Aug 29, 2025 · Payment Sep 15, 2025
Ex-dividend May 30, 2025
$0.16
Quarterly
Record May 30, 2025 · Payment Jun 16, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM17.03M0.02%77.55B USD0.19%$288.89+0.41%
Keeley Dividend ETFKDVD16.99M2.05%8.3M USD0.90%$28.55540.00%
Vanguard Morningstar Total Stock Market ETFVTI16.99M0.00%2.3T USD0.03%$376.31+0.82%
Fidelity Enhanced Small Cap ETFFESM8.34M0.13%6.49B USD0.28%$46.36+0.78%
Vanguard Extended Market ETFVXF6.4M0.01%93.7B USD0.05%$237.76+0.68%
iShares Russell 2000 Growth ETFIWO6.23M0.04%14.32B USD0.24%$367.63+0.54%
Janus Henderson Small Cap Growth Alpha ETFJSML3.67M1.02%358.9M USD0.30%$86.76+0.45%
Principal U.S. Small-Cap Multi-Factor ETFPSC3.57M0.13%2.7B USD0.38%$68.04+0.41%iShares Russell 2000 ETFIWMKeeley Dividend ETFKDVDVanguard Morningstar Total Stock Market ETFVTIFidelity Enhanced Small Cap ETFFESMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOJanus Henderson Small Cap Growth Alpha ETFJSMLPrincipal U.S. Small-Cap Multi-Factor ETFPSCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
